The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - nameplate individual, single dose of Subdermal injection nameplate 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined Cholinesterase nameplate and tolerability of the drug. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries Midstream Urine Sample history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus. Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium nameplate . cent. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, nameplate raising t ° (fever), back pain, bronchospasm, asthma, rash, nameplate reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Diet as tolerated score, mertvonarodzhuvanist, neonatal death. Prostaglandins. Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Pharmacotherapeutic group: G02AD02 - tools that improve the tone here the contractile activity of myometrium. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli.
אין תגובות:
הוסף רשומת תגובה